SAN JOSE, Calif.–(BUSINESS WIRE)–SpineAlign Medical Inc. announced today that it has chosen a new trademark name, VerteLift, for its vertebral implant system. Formerly called the SpineAlign System, the name reflects the advantages of the product that the Company will leverage going forward.
The VerteLift System is designed for the treatment of vertebral compression fractures and features an innovative nitinol implant, designed to achieve vertebral body reconstruction via a transpedicular, minimally invasive approach.
The VerteLift System represents the first of many new innovations in the area of minimally invasive percutaneous vertebral body reconstruction to come from SpineAlign Medical. The VerteLift device is a vertebral body implant designed to treat fractures in the thoracic or lumbar spine in patients suffering from osteoporosis. The VerteLift Implant is an expandable metal device composed of a nickel-titanium (nitinol) alloy that provides internal scaffolding to engage the vertebral body endplates, maintaining lift until bone cement is injected. VerteLift is available in two shapes and a range of sizes to address different anatomical needs for the treatment of vertebral compression fractures. Bone cement provides the long-term load bearing support. Prior to injection of bone cement, the VerteLift Implant is fully retrievable for repositioning or complete removal. The VerteLift System is not yet available for sale in the United States and is currently in clinical evaluation intended to support its 510(k) filing with the FDA. The VerteLift System is in commercial distribution in Europe.
SpineAlign Medical, Inc., is an early-stage medical device company dedicated to the design, development and successful commercialization of minimally-invasive products for spine procedures.